Within his role as a Partner at ClearView Healthcare Partners, Mike assists clients in developing product and therapeutic area strategies and provides a unique perspective on global pricing, reimbursement, and market access. In addition to broad therapeutic area knowledge, Mike has expertise in characterizing the roles and impact of organized customers, including regulators, payers, distributors, hospital systems, and provider groups. He places significant importance on professional mentorship, client focus, and developing practical solutions for complex business needs.
Mike began his life-sciences career in genomics research before transitioning into healthcare policy and finally establishing himself in consulting. Over the last 10 years he has focused on addressing strategic business issues for leading pharmaceutical and biotechnology companies. Prior to joining ClearView, Mike held positions at Leerink Swann, Double Helix and Campbell Alliance.
Mike holds an MBA from the College of William and Mary and a Master of Public Policy focused on pharmaceutical pricing regulations from Georgetown University.
Debbi Amanti Belanger
Klaus Bredl
Seth Berman
Steven Chao
Rishi Dalsania
David Gilman
Kim Goh
Ketan Kapadia
Philip Kenner
Eva Kersey
Stuart MacGregor
David McClain
Richard Mynahan
Kevin Richard
Mike Rizzo
Mike Roy
Bill Shew
Ryan Tubman
Sam Ulin
Debbie Zhuang
Jim Caruso
Sidnee Pinho
Kristine Hyde
Jonathan Betts
Dean Griffiths
Jonathan Hodgson
Slater Hurst
Andrew Kang
Dave Konciak
Alexander Lehrman
Charles Mathews
Olivia Piccione
Kai-Ming Pu
Sarah Stapleton
Brian Quinn
Michael Agne
Jessica Berard
Beko Binder
Liang Dong
Maneesh Gujrati
Peter Goldman
Austin Hubbert
Owen Im
Jonny Juliano
Patrick Kuettner
Joanna Lee
Alec Marchuk
Matthew Murphy
Mike Murray
Soyeon Park
Matthew Pfister
Cem Salfati
Kelsey Yardumian
Lainey Miller
Melanie Robinson